AI brief of an SEC Form 8-K · GE HealthCare (GEHC)
GE HealthCare Q3 revenue up 7.2%, diluted EPS $1.36; raises 2026 EPS guidance
GE HealthCare reported third quarter 2026 revenue of $5.5 billion, up 7.2%, and net income attributable to the company of $615 million versus $446 million a year earlier. The company raised its full-year 2026 adjusted EPS guidance to $4.95 to $5.05, and also disclosed that Jeannette Bankes, President and CEO of Patient Care Solutions, will resign effective November 15, 2026, with Neal Sandy succeeding her on November 16.
Key points
- Q3 2026 revenue of $5.5 billion, up 7.2% (organic growth 6.2%); diluted EPS of $1.36 versus $0.98; adjusted EPS of $1.34 versus $1.07
- Full-year 2026 adjusted EPS guidance raised to $4.95 to $5.05, from $4.80 to $5.00; organic revenue growth now about 4.0%
- Jeannette Bankes to resign as President and CEO, Patient Care Solutions, with last day November 15, 2026; Neal Sandy to become President and CEO on November 16, 2026
- Company plans to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, expected to close in the first half of 2027
The filing
CompanyGE HealthCare (GEHC)
Form8-K, current report
Filed with the SECOct 28, 2026, 6:25 AM ET
Accession number0001932393-26-000058
Written by AI on Nov 7, 2026, 11:18 PM ET, from this filing only.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.